Cargando…
The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial
Background: Fatigue is a common complication associated with multiple sclerosis (MS). The aim of this study was to evaluate the impact of dalfampridine and amantadine on fatigue in patients with MS. Methods: This was a randomized, double-blind, clinical trial on patients with MS. The recruited patie...
Autores principales: | Sadeqi, Yasaman, Baghbanian, Seyed Mohammad, Bazi, Aliyeh, Ghazaeian, Monireh, Fallah, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189202/ https://www.ncbi.nlm.nih.gov/pubmed/38011342 http://dx.doi.org/10.18502/cjn.v21i4.11717 |
Ejemplares similares
-
Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation
por: Bazi, Aliyeh, et al.
Publicado: (2021) -
A Clinical Monitoring Program of COVID-19 Outpatients: A Prospective Cohort Study
por: Kasiri, Hossein, et al.
Publicado: (2021) -
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial
por: Kasiri, Hossein, et al.
Publicado: (2021) -
Dalfampridine effects on cognition, fatigue, and dexterity
por: Korsen, Melanie, et al.
Publicado: (2016) -
Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis
por: Khazaei, Mojtaba, et al.
Publicado: (2019)